Vision Therapy for Intermittent Exotropia
(VT-IXT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether vision therapy (also known as orthoptics, vision training, or eye exercises) can help control intermittent exotropia, a condition where one or both eyes occasionally turn outward, especially when viewing distant objects. Participants will either undergo 20 weeks of vision therapy or be observed without treatment to assess any improvement. The trial aims to determine if vision therapy is effective enough in the short term to warrant a longer study. It is suitable for children and teens aged 8 to 16 who experience intermittent exotropia and are comfortable with random assignment to either the therapy or observation group. As an unphased trial, this study provides a unique opportunity for participants to contribute to early research that could lead to new treatment options.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that vision therapy is safe for intermittent exotropia?
Research has shown that vision therapy, involving exercises for the eyes, is generally manageable for participants. One study found that adding eye exercises improved control over intermittent exotropia, a condition where one eye occasionally turns outward, for both near and distant focus. This study reported no significant negative effects.
Another study used a virtual reality game for eye training and also demonstrated positive results for intermittent exotropia, with no major safety issues reported. Overall, these findings suggest that vision therapy is safe, with no serious side effects noted in these studies.12345Why are researchers excited about this trial?
Researchers are excited about vision therapy for intermittent exotropia because it offers a non-surgical approach that focuses on improving eye coordination and control. Traditional treatments often involve surgery or corrective lenses, but vision therapy uses a series of exercises to strengthen the eye muscles and enhance visual skills. This approach could provide a more natural way to manage the condition, potentially reducing the need for more invasive procedures. Additionally, it empowers patients with at-home exercises, giving them an active role in their treatment journey.
What evidence suggests that vision therapy is effective for intermittent exotropia?
This trial will compare Vision Therapy with an Observation approach for managing intermittent exotropia (IXT). Studies have shown that vision therapy can improve the control of IXT, a condition where the eyes sometimes drift outward. One study demonstrated that vision therapy enhanced eye alignment when focusing on distant objects, with an improvement score of 1.3. Another study found that vision therapy significantly reduced eye misalignment both at a distance and up close. This therapy enhances the coordination of both eyes. These findings suggest that vision therapy can be a promising non-surgical treatment for managing IXT.26789
Who Is on the Research Team?
Angela Chen, OD, MS
Principal Investigator
Southern California College of Optometry at Marshall B. Ketchum University
Are You a Good Fit for This Trial?
This trial is for kids aged 8-16 with a specific eye alignment issue called intermittent exotropia, where one eye occasionally drifts outward. They should have certain levels of control over their eye movement and good depth perception. Kids who plan to move soon or can't commit to the study's process are not eligible.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 20 consecutive weeks of office-based vision therapy with home therapy
Observation
Participants in the observation group receive no treatment unless deterioration criteria are met
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Vision Therapy
Vision Therapy is already approved in United States, Canada, European Union for the following indications:
- Intermittent Exotropia
- Strabismus
- Convergence Insufficiency
- Intermittent Exotropia
- Strabismus
- Convergence Insufficiency
- Intermittent Exotropia
- Strabismus
- Convergence Insufficiency
Find a Clinic Near You
Who Is Running the Clinical Trial?
Southern California College of Optometry at Marshall B. Ketchum University
Lead Sponsor
Southern College of Optometry
Collaborator
Case Western Reserve University
Collaborator
Salus University
Collaborator
American Academy of Optometry
Collaborator
University of Alabama at Birmingham
Collaborator
Stanford University
Collaborator
Ohio State University
Collaborator